Skip to main content
OpenTrials

Clinical trial condition

Prurigo Nodularis

Explore clinical trials studying Prurigo Nodularis. Study availability and eligibility vary by location and protocol.

35 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Prurigo Nodularis trial results

Completed

Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis

NCT02174419

Conditions
Nodularis Prurigo, Pathological Conditions, Signs and Symptoms, Prurigo, +6 more
Locations
  • Case Western Reserve University Cleveland, Ohio, United States
  • Temple University Hospital Philadelphia, Pennsylvania, United States
  • University of Münster Münster, Germany
  • Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wroclawiu Wroclaw, Lower Silesian Voivodeship, Poland
View Trial Details
Completed

A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis

NCT05052983

Conditions
Prurigo Nodularis
Locations
  • Galderma Investigational Site 8521 Saint Joseph, Missouri, United States
  • Galderma Investigational Site 5471 Graz, Austria
  • Galderma Investigational Site 6158 Vienna, Austria
  • Galderma Investigational Site 5104 Brest, France
View all 14 locations
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501679

Conditions
Dermatitis, Neurodermatitis, Pathological Conditions, Signs and Symptoms, +8 more
Locations
  • Galderma Investigational Site Fountain Valley, California, United States
  • Galderma Investigational Site San Diego, California, United States
  • Galderma Investigational Site Washington D.C., District of Columbia, United States
  • Galderma Investigational Site Aventura, Florida, United States
View all 74 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501666

Conditions
Dermatitis, Neurodermatitis, Pathological Conditions, Signs and Symptoms, +8 more
Locations
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Los Angeles, California, United States
  • Galderma Investigational Site Sacramento, California, United States
View all 100 locations
View Trial Details
Completed

A Study of CDX-0159 in Patients With Prurigo Nodularis

NCT04944862

Conditions
Prurigo Nodularis
Locations
  • Desert Sky Dermatology Tempe, Arizona, United States
  • University of Miami, Dermatology Clinical Trials Unit Miami, Florida, United States
  • Revival Research Institute, LLC Troy, Michigan, United States
  • University of New Mexico Albuquerque, New Mexico, United States
View all 17 locations
View Trial Details
Completed

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

NCT03546816

Conditions
Pathological Conditions, Signs and Symptoms, Prurigo Nodularis, Pruritus, +4 more
Locations
  • Study Site 504 Birmingham, Alabama, United States
  • Study Site 533 Rogers, Arkansas, United States
  • Study Site 204 Fremont, California, United States
  • Study Site 383 North Hollywood, California, United States
View all 49 locations
View Trial Details

Related conditions